E
Universal Ibogaine Inc. IBO.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

04/30/2024 01/31/2024 10/31/2023 07/31/2023 04/30/2023
Net Income -76.87% 72.02% 75.80% 93.38% 61.22%
Total Depreciation and Amortization 11.05% 17.67% 23.90% 7.15% -5.49%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 762.58% -92.65% -86.08% -95.74% 0.63%
Change in Net Operating Assets -145.85% 578.33% -131.93% 108.48% -37.29%
Cash from Operations -190.64% 85.87% 59.88% 100.32% 78.95%
Capital Expenditure 55.06% 95.65% 66.72% 402.20% 52.27%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 55.06% 95.65% 66.72% -94.16% 52.27%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -697.56% -86.71% -74.89% 76.54% 98.49%
Issuance of Common Stock -- -- -81.46% -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 66.21% 56.56% -88.33% 34.85% 229.36%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -34.57% 139.91% -571.43% 96.88% 113.44%
Weiss Ratings